CTI 103 Pill — WHITE ROUND, 10mm — Diclofenac

No photo available

Imprint	CTI / 103
Colour	WHITE
Shape	ROUND
Size	10
Strength	DICLOFENAC SODIUM 75 mg
Dosage form	Tablet, Delayed Release
Manufacturer	PD-Rx Pharmaceuticals, Inc.
NDC	43063-694
Schedule	—
Availability	—
Ingredients	DICLOFENAC SODIUM[DICLOFENAC]

What does this imprint mean?

The imprint "CTI 103" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Diclofenac

Uses and warnings

BOXED WARNING: Cardiovascular Thrombotic Events - "NSAIDs cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal." Gastrointestinal Risk - "NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal." Contraindicated in patients with prior hypersensitivity, including those who "have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs." Additional warnings cover hepatic reactions - "elevations of one or more liver tests may occur" and "rare cases of severe hepatic reactions, including jaundice and fatal fulminant hepatitis, have been reported."

Diclofenac sodium delayed-release tablets are indicated for "the acute and chronic treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis."

Read the full drug profile →